Related Experiment Videos
[Corticophobia in asthma].
Adrian Gillissen1, Josef Lecheler
1Robert-Koch-Klinik, Klinikum St. Georg, Leipzig. adrian.gillissen@sanktgeorg.de
Medizinische Klinik (Munich, Germany : 1983)
|August 21, 2003
Summary
Physicians may overestimate patient concerns about inhaled corticosteroids for asthma. Patients express less worry about these medications than doctors assume, indicating a need for personalized treatment adjustments.
Area of Science:
- Pulmonology and Respiratory Medicine
- Clinical Pharmacy
- Patient Adherence Studies
Context:
- Steroid phobia is a significant barrier to effective asthma management, leading to poor patient compliance.
- Understanding patient and physician perspectives on inhaled corticosteroids (ICS) is crucial for optimizing asthma care.
- Physician assumptions about patient concerns regarding ICS may not align with patient realities.
Purpose:
- To investigate patient and general practitioner (GP) perceptions of inhaled corticosteroids (ICS) in asthma management.
- To compare physicians' assumptions about patient concerns with actual patient responses regarding ICS.
- To assess patient knowledge and information needs related to asthma medication.
Summary:
- Physicians overestimated patient desire to discontinue inhaled corticosteroids (ICS) compared to actual patient responses.
- Patients expressed lower concerns about ICS side effects than physicians perceived, particularly in children.
- A significant knowledge gap regarding asthma medication use and function was not identified; however, patients desired more information.
Impact:
- Physician overestimation of patient concerns regarding ICS may lead to suboptimal treatment decisions.
- This highlights a potential disconnect in communication and perception between healthcare providers and asthma patients.
- Individualized assessment and alternative anti-inflammatory treatments should be considered for patients hesitant about corticosteroid therapy.